Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heidelberg University

www.uni-heidelberg.de

Latest From Heidelberg University

Recent Financings of Private Companies (10/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

Sensing the State of the CRM Market

After years of steady single-digit growth, the cardiac rhythm management market was jump-started this decade by the expansion of implantable cardioverter defibrillators and the development of cardiac resynchronization therapy devices. Those products drove annual growth rates above 20%. But in 2005, this growth came to a screeching halt due to product recalls and other safety issues. To address these concerns, CRM manufacturers are working with the FDA and the Heart Rhythm Society to restore the trust of both implanting physicians and the patient community.
Medical Device

HepaVec AG

With technology licensed from the Max Planck Society, HepaVec is developing liver-specific viral vector systems for human gene therapy. Also liver tissue engineering.
BioPharmaceutical
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register